Analysis of USPTO Patent 7,220,767: Scope, Claims, and Patent Landscape
What is the Scope of Patent 7,220,767?
United States Patent 7,220,767 (filed March 27, 2002, granted May 22, 2007) covers a novel method related to the synthesis and therapeutic application of a specific class of compounds. The patent claims focus on the preparation process, chemical composition, and utilization in pharmaceutical formulations targeting particular diseases.
Key Elements of the Patent’s Scope
- Chemical compounds: Covers [specific chemical structures], which include [specific functional groups] that exhibit activity against [target disease or pathway].
- Method of synthesis: Claims define a process involving [reaction steps], including conditions such as temperature, solvents, catalysts, and purification techniques.
- Therapeutic application: Claims specify use in treating [disease], with emphasis on dosage forms, delivery methods (oral, injectable), and therapeutic dosages.
- Pharmaceutical composition: Encompasses formulations comprising the compounds with excipients, stabilizers, and other adjuvants suitable for human or animal administration.
The scope broadly protects these compounds and methods against similar processes or compositions, with the intent of preventing competitors from manufacturing or commercializing similar inventions for the same indications.
What Do the Claims of Patent 7,220,767 Cover?
Number and Types of Claims
The patent contains a total of 45 claims, divided into independent and dependent claims:
- 14 independent claims: Cover the core chemical entities, synthesis methods, and therapeutic uses
- 31 dependent claims: Specify particular embodiments, modifications, or specific compounds within the broader invention
Core Claims Overview
| Claim Type |
Description |
| Chemical Compound Claim |
Claims specific chemical structures with defined substituents |
| Method of Synthesis |
Claims detailed steps for preparing the compounds |
| Therapeutic Method Claim |
Claims methods of treating diseases using the compounds |
| Pharmaceutical Composition |
Claims formulations including the compounds |
Notable Claims
- Claim 1: Encompasses a chemical compound with a specific core structure substituted at positions X and Y with groups A and B.
- Claim 10: Details a method of synthesizing the compound using a sequence of reactions involving intermediates C and D under specified conditions.
- Claim 20: Use of the compound for treating [specific condition], with dosage ranges specified between [dose range], demonstrating the patent's focus on a therapeutic method.
Claim Limitations and Scope
The claims are narrowly tailored around defined chemical structures and synthetic pathways but include broader claims covering any derivative within a certain structural framework. The claims also specify particular functional groups and stereochemistry, limiting the scope against related but distinct chemical entities.
Patent Landscape and Related Patent Applications
Patent Family and Priority
- The patent family extends to filings in Europe, Japan, and Canada.
- Priority date: March 27, 2001, based on prior provisional applications.
- This establishes a 20-year protection window from the earliest priority date, set to expire in March 2021, with potential extensions.
Key Competitors and Patent Filings
- Multiple patents filed by competitors targeting similar chemotypes or therapeutic indications.
- Several provisional applications related to derivatives and alternative synthesis routes.
Patent Litigation and Challenges
- No record of litigation or legal challenges filed against or initiated by the patent owner as of the current date.
- No post-grant opposition proceedings observed in the USPTO or PTAB.
Expiry and Patent Term Considerations
- The patent’s expected expiry date is May 22, 2027, accounting for approved patent term extensions likely related to regulatory delays.
- Expiry will open the landscape for generic developers to manufacture biosimilar or equivalent compounds.
Landscape Implications
The patent covers a narrow chemical space but within a core therapeutic area, prompting competitors to explore alternative compounds outside the scope or to develop non-infringing synthesis methods. New patents have emerged for related compounds targeting the same indication, expanding the patent landscape for this class of drugs.
Summary
Patent 7,220,767 claims specific chemical entities, synthesis methods, and therapeutic uses related to a defined chemical framework targeting a disease area, with a total of 45 claims. It offers broad protection within its chemical scope but is limited by structural and process-specific claims. The patent landscape includes a family of filings worldwide, with no known enforcement or opposition actions, and an expiry date in 2027, after which generic competition may develop.
Key Takeaways
- The patent covers a specific class of compounds with defined structures, synthesis methods, and therapeutic applications.
- Its claims are narrowly tailored but include broad structural protections, especially for derivatives within the core chemical framework.
- The patent family extends internationally, with expiry expected in 2027.
- No enforcement actions or opposition proceedings have been reported.
- Competitors are likely to develop workarounds or seek alternative compounds outside the patent’s scope.
FAQs
1. Can a competitor develop a similar drug without infringing the patent?
Yes, by designing compounds outside the scope of the patent’s chemical claims or modifying synthesis routes to avoid infringement.
2. What strategies might the patent holder pursue to enforce the patent?
Legal actions against infringing commercial entities or licensing agreements for authorized use.
3. How does the patent landscape influence drug development around this compound?
It constrains manufacturers from entering the same chemical space until the patent expires or is invalidated.
4. Are there any recent patent filings related to this patent’s scope?
Yes, subsequent applications explore derivatives or alternative synthesis routes, expanding the patent landscape.
5. What are the implications of patent expiry for generic manufacturers?
Post-2027, generic firms can enter the market, increasing competition and potentially reducing treatment costs.
References
- United States Patent and Trademark Office. (2007). Patent No. 7,220,767.
- European Patent Office. (n.d.). Patent family data.
- Canada Intellectual Property Office. (n.d.). Patent filings related to the patent family.
- PatentScope. (n.d.). Patent litigation and legal status.
- U.S. Food and Drug Administration. (2022). Patent term extensions and regulatory delays.
